| pubmed-article:3267102 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3267102 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:3267102 | lifeskim:mentions | umls-concept:C0016030 | lld:lifeskim |
| pubmed-article:3267102 | lifeskim:mentions | umls-concept:C0027022 | lld:lifeskim |
| pubmed-article:3267102 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:3267102 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
| pubmed-article:3267102 | lifeskim:mentions | umls-concept:C1947989 | lld:lifeskim |
| pubmed-article:3267102 | lifeskim:mentions | umls-concept:C1948023 | lld:lifeskim |
| pubmed-article:3267102 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:3267102 | pubmed:dateCreated | 1989-9-5 | lld:pubmed |
| pubmed-article:3267102 | pubmed:abstractText | Sera of patients with primary myelofibrosis (PMF), primary thrombocythemia (PT), polycythaemia vera (PV) and chronic myeloid leukemia (CML) contained a significantly increased F-CSA (or F-CSAs) compared to those of normal subjects and patients with secondary thrombocytosis (ST). This F-CSA was heat sensitive and had the capacity to promote both proliferation and maturation of normal marrow fibroblast colony-forming cells (CFU-F). This F-CSA seemed to be different from human platelet derived growth factor (PDGF), tumor necrosis factor (TNF) and fibroblast growth factor (FGF) from bovine brain. This F-CSA might be of importance in the pathogenesis of bone marrow fibrosis in myeloproliferative disorders. | lld:pubmed |
| pubmed-article:3267102 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3267102 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3267102 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3267102 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3267102 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3267102 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3267102 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3267102 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3267102 | pubmed:issn | 0393-974X | lld:pubmed |
| pubmed-article:3267102 | pubmed:author | pubmed-author:BriereJJ | lld:pubmed |
| pubmed-article:3267102 | pubmed:author | pubmed-author:ParentDD | lld:pubmed |
| pubmed-article:3267102 | pubmed:author | pubmed-author:AbgrallJ FJF | lld:pubmed |
| pubmed-article:3267102 | pubmed:author | pubmed-author:SensebeLL | lld:pubmed |
| pubmed-article:3267102 | pubmed:author | pubmed-author:HanZ CZC | lld:pubmed |
| pubmed-article:3267102 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3267102 | pubmed:volume | 2 | lld:pubmed |
| pubmed-article:3267102 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3267102 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3267102 | pubmed:pagination | 119-24 | lld:pubmed |
| pubmed-article:3267102 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:3267102 | pubmed:meshHeading | pubmed-meshheading:3267102-... | lld:pubmed |
| pubmed-article:3267102 | pubmed:meshHeading | pubmed-meshheading:3267102-... | lld:pubmed |
| pubmed-article:3267102 | pubmed:meshHeading | pubmed-meshheading:3267102-... | lld:pubmed |
| pubmed-article:3267102 | pubmed:meshHeading | pubmed-meshheading:3267102-... | lld:pubmed |
| pubmed-article:3267102 | pubmed:meshHeading | pubmed-meshheading:3267102-... | lld:pubmed |
| pubmed-article:3267102 | pubmed:meshHeading | pubmed-meshheading:3267102-... | lld:pubmed |
| pubmed-article:3267102 | pubmed:meshHeading | pubmed-meshheading:3267102-... | lld:pubmed |
| pubmed-article:3267102 | pubmed:meshHeading | pubmed-meshheading:3267102-... | lld:pubmed |
| pubmed-article:3267102 | pubmed:meshHeading | pubmed-meshheading:3267102-... | lld:pubmed |
| pubmed-article:3267102 | pubmed:meshHeading | pubmed-meshheading:3267102-... | lld:pubmed |
| pubmed-article:3267102 | pubmed:meshHeading | pubmed-meshheading:3267102-... | lld:pubmed |
| pubmed-article:3267102 | pubmed:meshHeading | pubmed-meshheading:3267102-... | lld:pubmed |
| pubmed-article:3267102 | pubmed:meshHeading | pubmed-meshheading:3267102-... | lld:pubmed |
| pubmed-article:3267102 | pubmed:meshHeading | pubmed-meshheading:3267102-... | lld:pubmed |
| pubmed-article:3267102 | pubmed:meshHeading | pubmed-meshheading:3267102-... | lld:pubmed |
| pubmed-article:3267102 | pubmed:meshHeading | pubmed-meshheading:3267102-... | lld:pubmed |
| pubmed-article:3267102 | pubmed:meshHeading | pubmed-meshheading:3267102-... | lld:pubmed |
| pubmed-article:3267102 | pubmed:meshHeading | pubmed-meshheading:3267102-... | lld:pubmed |
| pubmed-article:3267102 | pubmed:articleTitle | Increased fibroblast colony stimulating activity (F-CSA) in serum of myeloproliferative disorders. | lld:pubmed |
| pubmed-article:3267102 | pubmed:affiliation | Department of Hematology, A. Morvan Hospital, Brest University School of Medicine, France. | lld:pubmed |
| pubmed-article:3267102 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3267102 | pubmed:publicationType | Comparative Study | lld:pubmed |
